Transgene SA
TRGNF
$0.85
-$0.15-15.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.85% | -10.86% | -23.42% | -13.46% | -169.44% |
| Total Depreciation and Amortization | 6.96% | 4.13% | 15.67% | 6.34% | -13.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -84.10% |
| Total Other Non-Cash Items | 157.12% | 155.63% | 966.84% | 881.39% | 81.21% |
| Change in Net Operating Assets | -125.36% | -124.70% | 47.30% | 51.55% | 547.07% |
| Cash from Operations | -316.00% | -305.10% | -2.10% | 6.14% | 70.81% |
| Capital Expenditure | 42.10% | 43.63% | 85.32% | 86.50% | 16.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -16,296.69% | -15,865.23% | -159.34% | -154.54% | -103.85% |
| Cash from Investing | -6,436.98% | -6,265.65% | 56.76% | 60.25% | -110.45% |
| Total Debt Issued | -1.50% | -1.50% | 1.50% | 1.50% | -- |
| Total Debt Repaid | 100.00% | 100.00% | 98.54% | 98.54% | 87.46% |
| Issuance of Common Stock | 94,595.50% | 94,595.50% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 7.77% | 7.77% | -159.60% | -159.60% | 115.21% |
| Cash from Financing | 1,520.78% | 1,478.32% | 9.88% | 1.02% | -37.73% |
| Foreign Exchange rate Adjustments | -184.81% | -182.63% | -469.53% | -439.80% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -918.35% | -896.85% | 131.10% | 128.59% | -88.81% |